Impaired Awareness of Hypoglycemia in Type 1 Diabetes : A Report of An NIDDK Workshop in October 2021
© 2022 by the American Diabetes Association..
Hypoglycemia remains a limiting factor in the optimal treatment of type 1 diabetes. Repeated episodes of hypoglycemia result in impaired awareness of subsequent hypoglycemic events, inducing a vicious feed-forward cycle and increasing the risk of morbidity and mortality. Why this occurs and how to manage the problem in clinical practice remain uncertain. To address the obstacles and barriers that have hindered progress in this clinically important area, the National Institute of Diabetes and Digestive and Kidney Diseases convened a workshop on 14-15 October 2021. This perspective offers a summary of this outstanding meeting, which brought clinical and basic scientists from the fields of diabetes, neuroscience, psychology, psychiatry, and imaging together, on how to best advance the field of impaired awareness of hypoglycemia and hypoglycemia in general in patients with diabetes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Diabetes care - 45(2022), 12 vom: 01. Dez., Seite 2799-2805 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Seaquist, Elizabeth R [VerfasserIn] |
---|
Links: |
---|
Themen: |
Hypoglycemic Agents |
---|
Anmerkungen: |
Date Completed 05.12.2022 Date Revised 02.12.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2337/dc22-1242 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349677409 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349677409 | ||
003 | DE-627 | ||
005 | 20231226043210.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2337/dc22-1242 |2 doi | |
028 | 5 | 2 | |a pubmed24n1165.xml |
035 | |a (DE-627)NLM349677409 | ||
035 | |a (NLM)36455118 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Seaquist, Elizabeth R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impaired Awareness of Hypoglycemia in Type 1 Diabetes |b A Report of An NIDDK Workshop in October 2021 |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.12.2022 | ||
500 | |a Date Revised 02.12.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 by the American Diabetes Association. | ||
520 | |a Hypoglycemia remains a limiting factor in the optimal treatment of type 1 diabetes. Repeated episodes of hypoglycemia result in impaired awareness of subsequent hypoglycemic events, inducing a vicious feed-forward cycle and increasing the risk of morbidity and mortality. Why this occurs and how to manage the problem in clinical practice remain uncertain. To address the obstacles and barriers that have hindered progress in this clinically important area, the National Institute of Diabetes and Digestive and Kidney Diseases convened a workshop on 14-15 October 2021. This perspective offers a summary of this outstanding meeting, which brought clinical and basic scientists from the fields of diabetes, neuroscience, psychology, psychiatry, and imaging together, on how to best advance the field of impaired awareness of hypoglycemia and hypoglycemia in general in patients with diabetes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Review | |
650 | 7 | |a Hypoglycemic Agents |2 NLM | |
700 | 1 | |a Teff, Karen |e verfasserin |4 aut | |
700 | 1 | |a Heller, Simon R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes care |d 1979 |g 45(2022), 12 vom: 01. Dez., Seite 2799-2805 |w (DE-627)NLM00042983X |x 1935-5548 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2022 |g number:12 |g day:01 |g month:12 |g pages:2799-2805 |
856 | 4 | 0 | |u http://dx.doi.org/10.2337/dc22-1242 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2022 |e 12 |b 01 |c 12 |h 2799-2805 |